 Blood Glucose Self-Monitoring
"Blood Glucose Self-Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.
| Descriptor ID |
D015190
|
| MeSH Number(s) |
E01.370.225.124.100.105 E01.370.374.100 E01.370.520.100 E02.900.100 E05.200.124.100.105
|
| Concept/Terms |
Blood Glucose Self-Monitoring- Blood Glucose Self-Monitoring
- Blood Glucose Self Monitoring
- Glucose, Blood, Self-Monitoring
- Self-Monitoring, Blood Glucose
- Blood Glucose Self-Monitorings
- Glucose Self-Monitoring, Blood
- Glucose Self-Monitorings, Blood
- Self Monitoring, Blood Glucose
- Self-Monitorings, Blood Glucose
- Monitoring, Home Blood Glucose
- Blood Sugar Self-Monitoring
- Blood Sugar Self Monitoring
- Blood Sugar Self-Monitorings
- Self-Monitoring, Blood Sugar
- Self-Monitorings, Blood Sugar
- Sugar Self-Monitoring, Blood
- Sugar Self-Monitorings, Blood
- Home Blood Glucose Monitoring
- Glucose, Blood, Self Monitoring
|
Below are MeSH descriptors whose meaning is more general than "Blood Glucose Self-Monitoring".
Below are MeSH descriptors whose meaning is more specific than "Blood Glucose Self-Monitoring".
This graph shows the total number of publications written about "Blood Glucose Self-Monitoring" by people in this website by year, and whether "Blood Glucose Self-Monitoring" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 3 | 3 | | 2000 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 1 | 2 | | 2004 | 3 | 1 | 4 | | 2005 | 0 | 1 | 1 | | 2006 | 1 | 0 | 1 | | 2007 | 1 | 2 | 3 | | 2008 | 1 | 2 | 3 | | 2009 | 5 | 0 | 5 | | 2010 | 1 | 2 | 3 | | 2011 | 1 | 2 | 3 | | 2012 | 3 | 2 | 5 | | 2013 | 3 | 6 | 9 | | 2014 | 3 | 10 | 13 | | 2015 | 7 | 4 | 11 | | 2016 | 4 | 8 | 12 | | 2017 | 11 | 7 | 18 | | 2018 | 12 | 15 | 27 | | 2019 | 11 | 16 | 27 | | 2020 | 11 | 22 | 33 | | 2021 | 8 | 24 | 32 | | 2022 | 1 | 45 | 46 | | 2023 | 7 | 27 | 34 | | 2024 | 21 | 20 | 41 | | 2025 | 19 | 22 | 41 | | 2026 | 3 | 5 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Blood Glucose Self-Monitoring" by people in Profiles.
-
Chen NC, Shah VN, McQueen RB. Time in Range and Incident Diabetic Retinopathy: Clinical and Economic Evidence From Real-World Type 1 Diabetes Care. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):e1146-e1152.
-
Akturk HK, Karakus KE, Chen B, Walker TC. Exploring the Relationship Between Newly Defined Continuous Glucose Monitoring (CGM) Metrics and the Standard CGM Metrics in 30,000 People with Type 1 Diabetes. Diabetes Technol Ther. 2026 Mar; 28(3):264-270.
-
Akturk HK, Karakus KE, Cengiz D, Mason E, Beck E, Kaur G, Garg SK. Glucose Control and Continuous Glucose Monitoring Metrics During 12 Months of Treatment with Tirzepatide in Overweight or Obese Patients with Type 1 Diabetes. Diabetes Technol Ther. 2026 Mar; 28(3):193-200.
-
Umpierrez GE, Shah VN, Brady V, Clements MA, Espinoza J, Healey E, Kohn MA, Maahs DM, Oiknine R, Seley JJ, Weitzman SP, Kerr D, Akturk HK, Aleppo G, Al-Sofiani ME, Cengiz E, Doyle FJ, Ebekozien O, Edelman SV, Ekhlaspour L, Freckmann G, Heinemann L, Hirsch IB, Hsiao VC, Kim SH, Kovatchev B, Lal RA, Lind M, Mader JK, Mathioudakis N, McLaughlin T, Meo SA, Osafehinti DA, Phillip M, Prahalad P, Scheinker D, Snyder MP, Wang J, Wong JC, Wright EE, Shao MM, Scheideman AF, DuNova AY, Klonoff DC. Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report. J Diabetes Sci Technol. 2026 May; 20(3):695-707.
-
Montaser E, Williams C, Shah VN. Assessing Time Below Range as a Predictor of Severe Hypoglycemia: Insights From Six Clinical Trials. Diabetes Care. 2026 Mar 01; 49(3):483-489.
-
Nally LM, Sherr JL, Garg SK, Marks BE, Laffel LM, Pihoker C, Accacha SD, Thrasher JR, Abuzzahab MJ, Reed JH, Ekhlaspour L, Belapurkar S, Shulman DI, Sunil B, MacLeish SA, Latif K, Forlenza GP, Castorino K, Lal RA, Bode BW, Broyles FE, Carlson AL, Nwosu BU, Shin J, Ma H, Salbato A, Cordero TL, Treminio Y, McVean JJ, Rhinehart AS, Vigersky RA. Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor. Diabetes Technol Ther. 2026 Feb; 28(2):109-120.
-
Shah VN, Choudhary P, Halperin I, Rabbone I, Zaharieva DP, Messer L. Rethinking control-IQ+ technology: Simple strategies for easy optimization. Diabetes Obes Metab. 2026 May; 28(5):3502-3514.
-
Riveline JP, Renard E, Aleppo G, Bode BW, Brown SA, Castorino K, Hirsch IB, Kipnes MS, Laffel LM, Lal RA, Penfornis A, Shah VN, Thivolet C, Weinstock RS. Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel-group clinical trial sub-study. Diabetes Obes Metab. 2026 Mar; 28(3):2227-2236.
-
Jendle JH, Garg SK, Thivolet C, Weinstock RS, Hirsch IB, Evans M, Griffin KJ, Philis-Tsimikas A, Wheeler BJ, Kipnes MS, Carlson AL, Buckingham BA, Bhargava A, Bode BW, Lawson ML, Criego AB, McGill JB, Reed JCH, Prakasam G, Grunberger G, Girelli A, Martinez-Brocca MA, Christiansen MP, de Bock MI, Kudva YC, Lee SW, Yovanovich C, Shin JJ, Cordero TL, McVean JJF, Vigersky RA. Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial. Front Endocrinol (Lausanne). 2025; 16:1716587.
-
Benhalima K, Durnwald C, Sweeting A, Adams D, Addala A, Battelino T, Bergenstal RM, Carlson A, Donovan LE, Reis Franco D, Heverly J, Isaacs D, Khunti K, Kihara AB, Levitt N, Levy CJ, Lewer M, Mathiesen E, Murphy HR, Nishimura R, Polsky S, Ram U, Simmons D, Yamamoto JM, Tabák ÁG, Feig D, Scott EM. Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement. Lancet Diabetes Endocrinol. 2026 Feb; 14(2):157-177.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|